$75.56
0.05% day before yesterday
Nasdaq, May 30, 10:00 pm CET
ISIN
US5165441032
Symbol
LNTH

Lantheus Holdings Inc Stock price

$75.56
-28.78 27.58% 1M
-14.02 15.65% 6M
-13.90 15.54% YTD
-4.96 6.16% 1Y
+5.22 7.42% 3Y
+61.68 444.38% 5Y
+68.79 1,016.10% 10Y
Nasdaq, Closing price Fri, May 30 2025
+0.04 0.05%
ISIN
US5165441032
Symbol
LNTH
Sector

Key metrics

Market capitalization $5.23b
Enterprise Value $4.86b
P/E (TTM) P/E ratio 21.28
EV/FCF (TTM) EV/FCF 10.27
EV/Sales (TTM) EV/Sales 3.16
P/S ratio (TTM) P/S ratio 3.40
P/B ratio (TTM) P/B ratio 4.49
Revenue growth (TTM) Revenue growth 12.53%
Revenue (TTM) Revenue $1.54b
EBIT (operating result TTM) EBIT $450.25m
Free Cash Flow (TTM) Free Cash Flow $473.01m
Cash position $938.53m
EPS (TTM) EPS $3.55
P/E forward 14.79
P/S forward 3.32
EV/Sales forward 3.08
Short interest 14.97%
Show more

Is Lantheus Holdings Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,782 stocks worldwide.

Lantheus Holdings Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Lantheus Holdings Inc forecast:

12x Buy
92%
1x Hold
8%

Analyst Opinions

13 Analysts have issued a Lantheus Holdings Inc forecast:

Buy
92%
Hold
8%

Financial data from Lantheus Holdings Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,537 1,537
13% 13%
100%
- Direct Costs 553 553
12% 12%
36%
984 984
13% 13%
64%
- Selling and Administrative Expenses 378 378
24% 24%
25%
- Research and Development Expense 156 156
64% 64%
10%
513 513
4% 4%
33%
- Depreciation and Amortization 63 63
3% 3%
4%
EBIT (Operating Income) EBIT 450 450
5% 5%
29%
Net Profit 254 254
45% 45%
17%

In millions USD.

Don't miss a Thing! We will send you all news about Lantheus Holdings Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Lantheus Holdings Inc Stock News

Neutral
Seeking Alpha
18 days ago
Lantheus shares fell 25% post-Q1 2025 report due to disappointing EPS guidance and not meet analysts' expectations. EPS reduction was driven by flat PYLARIFY sales and changes in Medicare coverage, impacting profitability and gross margins. Strategic transformation includes divesting the low-margin SPECT segment and acquiring LMI and Evergreen to expand into lucrative Alzheimer's and cancer dia...
Positive
MarketBeat
18 days ago
Investors searching for high-quality opportunities in the pharmaceutical space should keep a close eye on stocks trading at extremely oversold levels. One of the most popular ways to measure this is through the Relative Strength Index (RSI), a technical momentum indicator that signals when a stock may be due for a rebound.
Neutral
PRNewsWire
24 days ago
LOS ANGELES , May 8, 2025 /PRNewswire/ -- The DJS Law Group announces that it is investigating claims on behalf of investors of Lantheus Holdings, Inc. ("Lantheus" or "the Company") (NASDAQ: LNTH) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued misleading statements and/or failed to disclose information pertinent to investors.
More Lantheus Holdings Inc News

Company Profile

Lantheus Holdings, Inc. engages in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its products are used by cardiologists, nuclear physicians, radiologists, internal medicine physicians, sonographers and technologists working in a variety of clinical settings. The firm operates through the following geographical segments: U.S. and International. The U.S. segment produces and markets medical imaging agents and products throughout the U.S. This segment sells its products to radio pharmacies, integrated delivery networks, hospitals, clinics and group practices. The International segment operations consist of production and distribution activities in Puerto Rico and direct distribution activities in Canada. The company was founded in 1956 and is headquartered in North Billerica, MA.

Head office United States
CEO Brian Markison
Employees 808
Founded 1956
Website www.lantheus.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today